MBA with Professional Certificate in Medication Risk

Friday, 10 July 2026 23:09:13

International Students can apply

Apply Now     Viewbook

MBA with Professional Certificate in Medication Risk

Overview

Medication Risk

is a critical concern in healthcare, and MBAs with Professional Certificate in Medication Risk equip professionals with the knowledge to mitigate these risks. This program is designed for healthcare professionals and pharmacists who want to enhance their skills in medication management. By understanding the complexities of medication interactions and adverse reactions, learners can improve patient outcomes and reduce healthcare costs. The program covers topics such as medication safety, regulatory compliance, and risk management strategies. With this knowledge, learners can make informed decisions and contribute to a safer healthcare environment. Explore this program further to learn more.

MBA with Professional Certificate in Medication Risk is a comprehensive program that equips students with the knowledge and skills to navigate the complex world of medication risk management. By combining the rigors of an MBA with a specialized certification in medication risk, this program offers career advancement opportunities in pharmaceutical, healthcare, and regulatory industries. Students will gain a deep understanding of medication risk assessment, mitigation strategies, and regulatory compliance. The program's unique focus on medication risk management sets it apart from other MBA programs, providing students with a competitive edge in the job market. (4)

Entry requirements

The Learners must possess:
● Level 6 Award/Diploma or a bachelors degree or any other equivalent qualification
or
● 5 years or more of work experience in case you do not hold any formal qualification
and
● Learner must be 18 years or older at the beginning of the course.


International Students can apply

Joining our world will be life-changing with a student body representing over 157 nationalities.

LSIB is truly an international institution with history of welcoming students from around the world. With us, you're not just a student, you're a member.

Course Content

•
Medication Safety and Risk Management •
Pharmacovigilance and Post-Marketing Surveillance •
Medication Error Prevention and Mitigation •
Regulatory Compliance and Governance in Medication Risk •
Medication Safety Culture and Organizational Change •
Risk Assessment and Prioritization in Medication Safety •
Medication Safety in Special Populations (e.g. Pediatrics, Geriatrics) •
Pharmacotherapy and Medication Use Review •
Medication Safety and Quality Improvement Initiatives •
International Regulatory Frameworks for Medication Risk

Assessment

The evaluation process is conducted through the submission of assignments, and there are no written examinations involved.

Fee and Payment Plans

30 to 40% Cheaper than most Universities and Colleges

Duration

The programme is available in two duration modes:

12 Months: GBP £7700
18 Months: GBP £6700
This programme does not have any additional costs.
The fee is payable in monthly, quarterly, half yearly instalments.
You can avail 5% discount if you pay the full fee upfront in 1 instalment

Payment plans

12 Months - GBP £7700

● Payment option (a) - GBP £770 x 10 monthly instalments
● Payment option (b) - GBP £2566 x 3 quarterly instalments
● Payment option (c) - GBP £3850 x 2 half yearly instalments
● Payment option (d) - GBP £7315 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

18 Months - GBP £6700

● Payment option (a) - GBP £478 x 14 monthly instalments
● Payment option (b) - GBP £1340 x 5 quarterly instalments
● Payment option (c) - GBP £2233 x 3 half yearly instalments
● Payment option (d) - GBP £6365 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

40% Cheaper

Our course fee is upto 40% cheaper than most universities and colleges.

Apply Now

Accreditation

 Stage 1 (Delivered by LSIB):
The programme involves delivery through on-line Learning Management System (LMS). This stage leads to award of Level 7 Diploma in Strategic Management and Leadership. Credits earned at this stage - 120 credits (60 ECTS).

Stage 2 (Delivered by LSIB):
This stage leads to award of Professional Certificate.

Stage 3 (Delivered by the University / awarding body)
On completion of the diploma programme you progress / Top up with Degree through a UK University for progression to the MBA degree. The stage 3 is delivered via distance learning by faculties from the University / awarding body. Credits earned at this stage - 60 credits (30 ECTS).

Apply Now

  • 1. Complete the online enrolment form and Pay enrolment fee of GBP £10.
  • 2. Wait for our email with course start dates and fee payment plans. Your course starts once you pay the course fee.
  • Apply Now
    •

Got questions? Get in touch

Chat with us: Click the live chat button

+44 75 2064 7455

admissions@lsib.co.uk

+44 (0) 20 3608 0144



Career path

Key facts about MBA with Professional Certificate in Medication Risk

The MBA with Professional Certificate in Medication Risk is a specialized program designed for healthcare professionals and pharmaceutical industry experts who want to enhance their knowledge and skills in medication safety and risk management. This program is designed to equip learners with the necessary knowledge and skills to identify, assess, and mitigate medication-related risks, ensuring patient safety and compliance with regulatory requirements.
The learning outcomes of this program include understanding medication safety principles, identifying medication errors, and developing strategies for risk management and mitigation.
The program is typically completed in 6-12 months, depending on the learner's prior experience and the number of credits required for completion.
The duration of the program can be adjusted to accommodate the needs of working professionals, ensuring minimal disruption to their careers.
The MBA with Professional Certificate in Medication Risk is highly relevant to the pharmaceutical industry, healthcare organizations, and regulatory bodies, as it addresses the growing concern of medication safety and risk management.
The program is designed to meet the needs of professionals working in various roles, including pharmacists, physicians, nurses, and quality assurance specialists.
The program's industry relevance is further enhanced by its alignment with regulatory requirements, such as those set by the FDA and the Joint Commission.
Graduates of this program can expect to enhance their career prospects, take on leadership roles, and contribute to the development of safer healthcare systems.
The program's focus on medication risk management and mitigation makes it an attractive option for professionals seeking to advance their careers in this field.
Overall, the MBA with Professional Certificate in Medication Risk is a valuable investment for professionals seeking to enhance their knowledge and skills in medication safety and risk management.

Why this course?

The significance of an MBA with a Professional Certificate in Medication Risk cannot be overstated in today's market. According to a recent survey by the Chartered Institute of Personnel and Development (CIPD), 75% of employers in the UK consider a postgraduate qualification to be essential for senior roles. Moreover, a study by the Higher Education Statistics Agency (HESA) revealed that 60% of business schools in the UK offer postgraduate programs in pharmacy and pharmaceutical sciences.
UK Employers' Perception of Postgraduate Qualifications
75%
60% of business schools in the UK offer postgraduate programs in pharmacy and pharmaceutical sciences

Who should enrol in MBA with Professional Certificate in Medication Risk?

Ideal Audience for MBA with Professional Certificate in Medication Risk Professionals in the healthcare sector, particularly those in pharmacy, nursing, and medical administration, are the primary target audience for this program.
Key Characteristics: Individuals with a passion for improving patient safety and reducing medication errors, typically with a background in healthcare or a related field, are well-suited for this program.
UK-Specific Statistics: In the UK, medication errors are a leading cause of patient harm, with an estimated 5,000 deaths per year attributed to adverse drug reactions (NHS, 2020). This program aims to equip professionals with the knowledge and skills to mitigate these risks and improve patient outcomes.
Learning Outcomes: Upon completion of the program, learners will gain a deeper understanding of medication risk management, including the identification of potential risks, assessment of medication safety, and development of strategies to mitigate these risks.